Abstract
Renal artery stenosis (RAS) is the anatomic narrowing of one or more of the arteries to the kidney(s), most commonly caused by atherosclerosis. This chapter will review the causes of renal artery stenosis (RAS), and the pathophysiological changes and clinical manifestations that may occur due to RAS. Additionally, it will discuss the noninvasive imaging tests that are used to demonstrate the presence of RAS, how to determine its hemodynamic significance, and the role percutaneous transluminal angioplasty and renal artery stent placement play in the treatment of RAS.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Goldblatt H, Lynch J, Hanzai RF, Summerville WW. Studies on experimental hypertension; production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med. 1934;59:347–79.
Textor SC, Lerman LO. Paradigm shifts in atherosclerotic renovascular disease: where are we now? J Am Soc Nephrol. 2015;26(9):2074–80.
Textor SC. Renal arterial disease and hypertension. Med Clin North Am. 2017;101:65–79.
Parikh SA, Shishehbor MH, Gray BH, White CJ, Jaff MR. SCAI expert consensus statement for renal artery stenting appropriate use. Catheter Cardiovasc Interv. 2014;84:1163–71.
Textor SC, McKusick MM. Renal artery stenosis: if and when to intervene. Curr Opin Nephrol Hypertens. 2016;25:144–51.
Messerli FH, Bangalore S. Renal denervation for resistant hypertension? N Engl J Med. 2014;370:1454–7.
Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, et al. Stenting and medical therapy for atherosclerotic renal artery stenosis. The CORAL trial. N Engl J Med. 2014;370:13–22.
Carr TM, Sabri SS, Turba UC, Park AW, Saad WEA, Angle JF, Matsumoto AH. Stenting for atherosclerotic renal artery stenosis. Tech Vasc Interv Radiol. 2010;12:134–45.
Olin JW, Froehlich J, Gu X, Bacharach JM, Eagle K, Gray BH, et al. The US registry for fibromuscular dysplasia: results in the first 447 patients. Circulation. 2012;125:3182–90.
O’Connor SC, Gornik HL. Recent developments in the understanding and management of fibromuscular dysplasia. JAHA. 2014;3:e001259.
Meuse MA, Turba UC, Sabri SS, Park AW, Saad WEA, Angle JF, Matsumoto AH. Treatment of renal artery fibromuscular dysplasia. Tech Vasc Interv Radiol. 2010;13:126–33.
Murphy TP, Cooper CC, Pencina KM, D'Agostino R, Massaro J, Cutlip DE, et al. Relationship of albuminuria and renal artery stent outcomes: results from the CORAL randomized clinical trial (Cardiovascular Outcomes with Renal Artery Lesions). Hypertension. 2016;68:1145–52.
Misra S, Khosla A, Allred J, Harmsen WS, Textor SC, McKusick MA. Mortality and renal replacement therapy after renal artery stent placement for atherosclerotic renovascular disease. J Vasc Interv Radiol. 2016;27(8):1215–24.
Lewis S, Kadian-Dodov D, Bansai A, Lookstein RA. Multimodality imaging of fibromuscular dysplasia. Abdom Radiol. 2016;41:2048–60.
Mamoulakis C, Tsarouhas K, Fragkiadoulak I, Heretis I, Wilks MF, Spandidos DA, et al. Contrast-induced nephropathy: basic concepts, pathophysiological implications and prevention strategies. Pharmacol Ther. 2017; 180: 99-112.
Idee J, Fretellier N, Robic C, Corot C. The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: a critical update. Crit Rev Toxicol. 2014;44:895–913.
Noory E, Sritharan K, Zeller T. To stent or not to stent? Update on revascularization for atherosclerotic renovascular disease. Curr Hypertens Rep. 2016;18:45.
De Bruyne B, Manoharan G, Pijls NHJ, Verhamme K, Madaric J, Bartunek J, et al. Assessment of renal artery stenosis severity by pressure gradient measurements. J Am Coll Cardiol. 2006;48:1851–5.
Leesar MA, Varma J, Shapira A, Fahsah I, Raza ST, Elghoul Z, et al. Prediction of hypertension improvement after stenting of renal artery stenosis: comparative accuracy of translesional pressure gradients, intravascular ultrasound, and angiography. J Am Coll Cardiol. 2009;53:2363–71.
Dangas G, Laird JR Jr, Mehran R, Lansky AJ, Mintz GS, Leon MB. Intravascular ultrasound-guided renal artery stenting. J Endovasc Ther. 2001;8:238–47.
Raman G, Adam GP, Halladay CW, Langberg VN, Asodo IA, Balk EM. Comparative effectiveness of management strategies for renal artery stenosis. An updated systematic review. Ann Intern Med. 2016;165:635–49.
Tegtmeyer CJ, Selby JB, Hartwell GD, Ayers C, Tegtmeyer V. Results and complication of angioplasty in fibromuscular disease. Circulation. 1991;83(suppl):I155–61.
Trinquart L, Mounier-Vehier C, Sapoval M, Gagnon N, Plouin P. Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension. 2010;56:525–32.
Yang YK, Zhang Y, Meng X, Yang KQ, Jiang XJ, Wu HY, et al. Clinical characteristics and treatment of renal artery fibromuscular dysplasia with percutaneous transluminal angioplasty: a long-term follow-up study. Clin Res Cardiol. 2016;105:930–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Uflacker, A., Matsumoto, A.H. (2018). Renal Artery Stenosis. In: Keefe, N., Haskal, Z., Park, A., Angle, J. (eds) IR Playbook. Springer, Cham. https://doi.org/10.1007/978-3-319-71300-7_26
Download citation
DOI: https://doi.org/10.1007/978-3-319-71300-7_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-71299-4
Online ISBN: 978-3-319-71300-7
eBook Packages: MedicineMedicine (R0)